Skip to content

Inogen INGN Return on equity

Return on equity at other companies

ResMed logo
ResMedRMD
25.2%-0.6pp
AdaptHealth logo
AdaptHealthAHCO
-5.2%-10.8pp
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
10.7%+0.9pp
Savara logo
SavaraSVRA
-80%+4.7pp
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
9.6%+1.5pp
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
-53.1%-17.4pp

Other financials

Income statement

See full
Revenue$85.1M+3.4%
Gross profit$44.9M+1.7%
Operating income-$9.3M-21.9%
Net income-$8.3M-34.8%
EPS (diluted)-$0.30-20.0%

Balance sheet

See full
Cash & equivalents$93.1M-21.7%
Total debt$16.9M-11.9%
Total equity$182.9M-7.6%
Total assets$285.9M-7.3%

Cash flow

See full
Operating cash flow-$6.7M+60.2%
CapEx$210.0K-28.1%
Free cash flow-$6.9M+59.6%

Valuation

See full
Market cap$174.63M-9.7%
Enterprise value$98.45M-9.5%
P/S0.5×-0.1×

Profitability

See full
Gross margin52.8%-2.6pp
Operating margin-9.1%-0.8pp
Net margin-7.1%-0.8pp
FCF margin0.4%

Returns & leverage

See full
Debt / equity0.1×0.0×
Current ratio3.1×0.0×

Where this comes from

Calculated from Inogen’s reported figures.

Based on trailing twelve months.

The official record: Inogen’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inogen's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inogen's return on equity?
Inogen (INGN) reported return on equity of -13.1% in Q1 2026.
How has Inogen's return on equity changed year-over-year?
Inogen's return on equity increased by 7.3% year-over-year, from -14.1% to -13.1%.
What is the long-term trend for Inogen's return on equity?
Over 5 years (2020 to 2025), Inogen's return on equity has grown at a 49.2% compound annual growth rate (CAGR), from -1.7% to -12.4%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.